Agent access to notifications on Post Market Review Medical Devices Compliance dashboard

Overview

From 19 October 2020, the process by which the Therapeutic Good Administration (TGA) engages with the sponsors has changed. A new medical device Post Market Review Compliance Dashboard  has been developed in TBS to respond to post market reviews. The new compliance dashboard is providing the sponsors with an efficient and secure way of responding to post market reviews.

At present, the Post Market Review Medical Devices Compliance portal does not grant access to authorised agents of sponsors. The purpose of this survey is to seek your input regarding the preferred way for granting access to authorised agents.

Please follow the link to provide additional feedback and suggestions related to Post Market Review Medical Devices Compliance dashboard. 

What happens next

Responses will be collected and used for guiding the TGA in improving the Post Market Review Devices Compliance dashboard.